纳米载体设计用于病原体启发的先天免疫激动剂输送
Griffin I Kane1, Meghan L Brassil1, Miranda B Diaz-Infante1
1Department of Biomedical Engineering, University of Massachusetts Amherst, Amherst, MA, USA; UMass Cancer Center, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Trends in immunology
|August 27, 2024
概括
新型纳米载体可以向癌细胞输送多种免疫刺激药物,增强抗瘤反应. 这些纳米材料载体的合理设计是有效的多抗激素免疫治疗的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 在癌症等复杂疾病中调节细胞因子签名显示了治疗潜力.
- 受病原体启发的先天免疫激动剂可以通过协同的细胞因子释放引起强烈的抗瘤反应.
研究的目的:
- 审查向目标细胞提供多种免疫激动剂的挑战和策略.
- 突出纳米载体在克服多抗激素免疫疗法输送障碍方面的关键作用.
主要方法:
- 讨论基于纳米材料的载体,用于多激素的输送.
- 对先天免疫受体的细胞外和细胞内定位的分析.
- 对各种纳米材料,它们的好处和药物输送的缺点的审查.
主要成果:
- 确保多种激动剂同时向相同的细胞递送是一种重要的战略挑战.
- 纳米载体对于克服与各种免疫受体局部化相关的分娩障碍至关重要.
- 不同的纳米材料在多激素递送方面具有不同的优点和缺点.
结论:
- 合理的纳米载体设计对于病原体启发的多抗体免疫疗法的成功至关重要.
- 需要先进的纳米载体策略,以有效地准癌症治疗的先天免疫受体.
更多相关视频
09:51Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
12.4K
08:29Engineering Chimeric Antigen Receptor-Natural Killer Cells Targeting Fungal Infections Using the Non-viral Sleeping Beauty Transposon System
Published on: October 4, 2024
770
相关概念视频
01:29Immune Response Against Viral Pathogens
765
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
765
01:39Receptor-mediated Endocytosis
104.2K
Overview
104.2K